PharmaMed 2026 highlights India’s pharma growth, innovation, and healthcare equity with focus on RDI, APIs self-reliance, and global leadership.
Read Moreclinical trial sites India
Scaling Pharma Exports: India Targets Double-Digit Growth After Crossing USD 30 Billion
Chintan Shivir on Scaling Pharma Exports reviews $30.47B milestone, 9.4% growth and ₹10,000 crore Biopharma SHAKTI push for global expansion.
Read More